Long-term cost effectiveness analysis of Ideglira vs. basal-bolus insulin regimen in type 2 diabetes mellitus in Spain.

Authors : Prades M, Lizán L, Hunt B, Ramirez de Arellano A

Year: 2016

Congress: ISPOR 21st Annual International Meeting

Download PDF

Subscribe to Outcomes´10

Name

E-mail

Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy

I have read and accepted the privacy policy